A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients
Purpose
To evaluate the real-world effectiveness and implementation strategies for mPATH-Lung, investigators propose a pragmatic, randomized controlled trial across an academic Learning Health System. The trial will contrast several approaches to participant outreach and will specifically target engaging fully powered cohorts of racial/ethnic minorities and rural residents.
Condition
- Lung Cancer
Eligibility
- Eligible Ages
- Between 50 Years and 77 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
Eligible patients will: - Meet the Medicare criteria for lung cancer screening, as updated in February 2022: - Age 50 - 77 years - Smoked at least 20 pack years - Current smoker or quit smoking within the past 15 years - Be established with a primary care provider within the Atrium Health Wake Forest Baptist health network (defined as having completed at least 1 primary care appointment in the past 6 months or have completed at least 2 primary care appointments within the past 18 months or being scheduled to see a health network primary care provider within the next 30 days). - Have a patient portal account or cellphone number listed in the electronic health record - Have a North Carolina address listed in the electronic health record
Exclusion Criteria
The following patients will be excluded: - Patients flagged as needing a language interpreter in the electronic health record for any language other than Spanish (electronic messages and intervention are deliverable in English or Spanish only) - Those for whom lung cancer screening would be or may be inappropriate: electronic health record Prior history of lung cancer electronic health record Chest CT within the last 12 months electronic health record Those meeting the HEDIS COL-E measure exclusion criteria based on significant comorbidities and/or frailty.
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Screening
- Masking
- Single (Investigator)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Arm A |
Patient portal message first followed by up to 3 reminder text messages. |
|
|
Experimental Arm B |
Text message only with up to 3 reminder text messages. |
|
|
Experimental Arm C |
Portal message only with no reminder messages. |
|
|
Active Comparator Usual Care Arm |
Patients receive usual care. |
|
Recruiting Locations
Winston-Salem, North Carolina 27157
More Details
- Status
- Recruiting
- Sponsor
- Wake Forest University Health Sciences
Detailed Description
Primary Objective: Evaluate the real-world effectiveness of mPATH-Lung in increasing lung cancer screening rates across diverse populations. Secondary Objectives - Compare the differential effectiveness of three outreach strategies for engaging participants with mPATH-Lung across vulnerable rural or ethnic/racial minority population subgroups. - Estimate the additional revenue generated by mPATH-Lung through increased screening and downstream care. - Evaluate the potential for over-screening and the impact of applying HEDIS-based exclusion criteria